BeStock  
Stocks › Biotechnology › ODTX

Odyssey Therapeutics ODTX

US equityMarket cap rank #3341Biotechnology
$18.08 −$0.05 (-0.28%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $18.08 0.00%
Open$18.01
Prev close$18.13
Day range$17.83 – $18.84
Volume264.1K
Market cap$868.90M
P/E (TTM)–
Dividend yield–

ODTX Stock News

Headlines matching Odyssey Therapeutics or the ODTX ticker, most recent first.

  • H.C. Wainwright Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $44Market news · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Keeps Their Buy Rating on Odyssey Therapeutics, Inc. (ODTX)TipRanks · 22 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)TipRanks · 6 Aug 2026 · Direct mention
  • Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30Market news · 6 Aug 2026 · Direct mention
  • H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $44Market news · 27 Aug 2026 · Direct mention
  • TD Cowen Maintains Odyssey Therapeutics(ODTX.US) With Buy RatingMarket news · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Metagenomi, Inc. (MGX) and Autolus Therapeutics (AUTL)TipRanks · 12 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 PositiveMarket news · 11 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Odyssey Therapeutics(ODTX.US), With a Forecast Between $16.96 to $40Market news · 3 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Capricor Therapeutics (CAPR) and Medtronic (MDT)TipRanks · 18 Jun 2026 · Direct mention
  • Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40Market news · 18 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ODTX.

Leave a comment

Scroll to Top